Table 2 Baseline patient BI-RADS characteristics

From: Multimodal prediction based on ultrasound for response to neoadjuvant chemotherapy in triple negative breast cancer

BI-RADS characteristics

TC (n = 173) n (%)

ETC (n = 110) n (%)

P value

Shape

  

0.004*

 Oval or round

71 (41.0)

27 (24.5)

 

 Irregular

102 (59.0)

83 (75.5)

 

Orientation

  

0.081

 Parallel

127 (73.4)

70 (63.6)

 

 Not parallel

46 (26.6)

40 (36.4)

 

Margin

  

<0.001*

 Circumscribed

90 (52.0)

28 (25.5)

 

 Not circumscribed

83 (48.0)

82 (74.5)

 

Echo pattern

  

0.012*

 Complex cystic-solid

6 (3.5)

14 (12.7)

 

 Hypoechoic

120 (69.4)

71 (64.5)

 

 Heterogeneous

47 (27.2)

25 (22.7)

 

Posterior feature

  

0.002*

 No posterior feature

28 (16.2)

31 (28.2)

 

 Enhancement

99 (57.2)

56 (50.9)

 

 Shadowing

28 (16.2)

22 (20.0)

 

 Combined pattern

18 (10.4)

1 (0.9)

 

Calcification

  

0.001*

 No

71 (41.0)

68 (61.8)

 

 Yes

102 (59.0)

42 (38.2)

 

Vascularity

  

0.188

 Absent

16 (9.2)

5 (4.5)

 

 Internal vascularity

44 (25.4)

36 (32.7)

 

 Vessels in rim

113 (65.3)

69 (62.7)

 

Architectural distortion

  

0.146

 No

13 (7.5)

14 (12.7)

 

 Yes

160 (92.5)

96 (87.3)

 

Duct change

  

0.715

 No

169 (97.7)

106 (96.4)

 

 Yes

4 (2.3)

4 (3.6)

 

Skin change

  

0.560

 No

162 (93.6)

101 (91.8)

 

 Yes

11 (6.4)

9 (8.2)

 

Edema

  

0.771

 No

165 (95.4)

106 (96.4)

 

 Yes

8 (4.6)

4 (3.6)

 
  1. P values were calculated using the chi-square test or Fisher’s exact test. An asterisk indicates a significant P value. BI-RADS breast imaging data and reporting system.